Linagliptin impurity P
| Product Name | Linagliptin impurity P |
|---|---|
| Alternate Names | Linagliptin Impurities, Impurities of Linagliptin |
| CAT No. | CS-AQ-00176 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 520.58 g/mol |
| Mol. For. | C₂₆H₃₂N₈O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Linagliptin |
| Purity | >98% |
| Therapeutic | Anti-Diabetic |
| Smileys | O=C(OC(C)(C)C)N[C@H]1CN(C(N2CC3=NC(C)=C4C=CC=CC4=N3)=NC(N(C)C(N5)=O)=C2C5=O)CCC1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Linagliptin impurity P, also known as 8-[(3R)-3-amino-1-piperidinyl]-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione, is a chemical compound that is used in the pharmaceutical industry as an impurity in the production of linagliptin, a medication used to treat type 2 diabetes.
Linagliptin impurity P is a synthetic compound that is not found naturally in the environment. It is classified as a purine derivative, and its molecular formula is C25H27N7O2. It has a molecular weight of 457.53 g/mol and a melting point of 250-255°C.
The usage of Linagliptin impurity P is strictly regulated in the pharmaceutical industry due to its potential impact on the safety and efficacy of linagliptin. It is important to monitor and control the presence of this impurity in linagliptin formulations to ensure the quality and purity of the final product.
In conclusion, Linagliptin impurity P is a synthetic compound used in the pharmaceutical industry as an impurity in the production of linagliptin. Its chemical properties and potential impact on the safety and efficacy of linagliptin make it an important component of the drug manufacturing process.
Get an Instant Quote
Related Compounds
Desalkyl N-nitroso Linagliptin | Linagliptin impurity X | Linagliptin Impurity 30 | Linagliptin impurity 14 | Linagliptin Impurity II | Bromobutene Linagliptin impurity VII | Linagliptin Impurity 3 | Linagliptin impurity F | Linagliptin Impurity 49 | Linagliptin Impurity I | Linagliptin Impurity 43 | Linagliptin Dimer Impurity | Linagliptin-d9 | Linagliptin Impurity 37 | Linagliptin Impurity G | Linagliptin Hydroxy Impurity | Linagliptin Impurity N | Linagliptin Glycosamine | N-Boc Linagliptin | N-nitroso Linagliptin Impurity C | Linagliptin N-Amino Acyl Impurity | Desmethyl N-nitroso Linagliptin | Linagliptin impurity J | Linagliptin Impurity 17 | Linagliptin tert-butyl carbamate | Linagliptin Impurity W | Linagliptin Impurity 4 | Linagliptin Impurity 75 HCl salt | Linagliptin impurity R | Linagliptin Methyldimer | Linagliptin Impurity 117 | Linagliptin Impurity 51 | N-Hydroxy Linagliptin | Linagliptin Impurity 9 | Desbutyl N-nitroso Linagliptin Impurity 52 | Linagliptin Impurity 41 | Linagliptin impurity U | Linagliptin Dimer Impurity | Linagliptin impurity Y | Linagliptin impurity E | Linagliptin impurity B | Linagliptin impurity O | Linagliptin-4-methylquinazolin-2-yl-methyl dimer | Linagliptin Impurity 106 | Linagliptin Impurity-VII | Desbutyl N-nitroso Linagliptin impurity 16 | Linagliptin impurity C | Linagliptin Impurity 40 | Linagliptin Pentahydroxy Impurity | Linagliptin Impurity 35 | N-nitroso linagliptin impurity 92 | Linagliptin Impurity D | Linagliptin Impurity 29 | Linagliptin Impurity 2 | Linagliptin N-Acetyl Impurity | Linagliptin Impurity 25 | Linagliptin Impurity 41 | Linagliptin Impurity 1 | Linagliptin Impurity T | Hydroxy Methyl Linagliptin | N-Phthalimide-linagliptin | Linagliptin Impurity 42 | Linagliptin impurity S | Linagliptin Dimer impurity (N-C-C-C Dimer) | Linagliptin impurity M | Linagliptin impurity V | Linagliptin Impurity Q | Linagliptin Impurity 38 | Linagliptin Impurity 36 | N-(6-Amino-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-5-pyrimidinyl)formamide |